Table 2.
Correlates of mortality among children with ART initiation
Univariate
| ||||
---|---|---|---|---|
Characteristic | HR | 95% CI | P | Number available for analysis |
Age at ART initiation | 1.03 | 0.93–1.14 | 0.553 | 278 |
Sex, female | 1.46 | 0.72–2.96 | 0.297 | 278 |
CD4% | 0.93 | 0.88–1.0 | 0.037 | 157 |
CD4 | 0.999 | 0.998–1.000 | 0.072 | 225 |
HIV RNA, log10 | 0.82 | 0.50–1.53 | 0.427 | 162 |
WHO stages | ||||
Stage 2 | 1.24 | 0.37–4.12 | 0.723 | 39 out of 278 |
Stage 3 | 1.68 | 0.70–4.07 | 0.246 | 90 out of 278 |
Stage 4 | 1.47 | 0.53–4.07 | 0.455 | 58 out of 278 |
Weight for age z score | 0.77 | 0.66–0.90 | <0.001 | 243 |
Height for age z score | 0.80 | 0.66–0.96 | 0.015 | 241 |
Anaemia | 4.04 | 1.68–9.79 | 0.002 | 192 |
Bold text indicates significant value. ART, anti-retroviral therapy; CI, confidence interval; HIV, human immunodeficiency virus; WHO, World Health Organization.